Coty (NYSE:COTY) Bolsa

Coty

Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.

Coty Inc

<ul>
<li>Coty to Overdrive Fragrance Category Across Price Points, from $5 to $500</li>
<li>Leading Position and Capabilities in Fragrances, Plus Multi-Category Expertise, to Fuel Expansion</li>
<li>On Track to Deliver Leading TSR Through Profit, EPS, and Free Cash Flow Expansion</li>
<li>Strong Progress Towards ~2x Leverage Target Exiting CY26</li>
</ul>

News

COTY

Coty To Showcase Strategic Vision And Financial Strength At CAGNY 2025: Margin Expansion, EPS Growth, And A Path To ~2x Leverage

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Coty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>)</h3>
<ul>
<li>On Feb. 10, Coty missed second-quarter earnings and revenue estimates. Sue Nabi, Coty&#8217;s CEO, said, &#8220;As we are now midway through our fiscal year, it is clear that FY25 is shaping up to be a pivotal year. On the one hand, the global beauty market continues to grow at a healthy pace, even if growth has moderated off of the elevated levels of the last few years, which benefited from more material pricing increases. And in this backdrop, fragrances of all price points continue to outperform most other beauty categories, which strongly benefits Coty&#8217;s business as fragrances account for over 60% of our revenues and an even bigger portion of our profits." The company's stock fell around 23% over the past month and has a <a href="https://www.benzinga.com/quote/COTY">52-week low of $5.54</a>.</li>
<li>RSI Value: 21.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>COTY Price Action: Shares of Coty fell 3% to close at $5.58 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">COTY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="862" height="783" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148.png" alt="" class="wp-image-786413" style="width:609px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148.png 862w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042534/image-148-768x698.png 768w" sizes="(max-width: 862px) 100vw, 862px" /></a></figure>
<h3 class="wp-block-heading">elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Feb. 6, e.l.f. Beauty reported quarterly earnings of 74 cents per share, which met the analyst consensus estimate and is unchanged from the same period last year. Quarterly revenue came in at $355.32 million, which beat the analyst consensus estimate of $329.67 million and is an increase over sales of $270.94 million from the same period last year. The company's stock fell around 38% over the past month and <a href="https://www.benzinga.com/quote/ELF">has a 52-week low</a> of $63.50.</li>
<li>RSI Value: 15.4</li>
<li>ELF Price Action: Shares of elf Beauty fell 2.6% to close at $73.00 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">ELF stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="877" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45.png" alt="" class="wp-image-786414" style="width:717px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45.png 877w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45-300x286.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042554/image-2-45-768x733.png 768w" sizes="(max-width: 877px) 100vw, 877px" /></a></figure>
<h3 class="wp-block-heading">Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>On Feb. 3, Cal-Maine Foods announced the acquisition of Feed Mill Operations in North Carolina. The company's stock fell around 17% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CALM">low of $54.88.</a></li>
<li>RSI Value: 27.5</li>
<li>CALM Price Action: Shares of Cal-Maine fell 1.1% to close at $279.45 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1">CALM shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="848" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149.png" alt="" class="wp-image-786418" style="width:653px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149-300x296.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18042729/image-149-768x758.png 768w" sizes="(max-width: 848px) 100vw, 848px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

CALM

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

The home that launched a branding dynasty is hitting the market. <a href="https://www.benzinga.com/25/02/43583058/super-bowl-ads-go-all-in-on-ai-stars-and-8m-price-tags-elon-musk-shared-this-advert-with-his-followers">Kris Jenner</a>, the Kardashian/Jenner manager, matriarch, and business maven, is selling the iconic checkerboard foyer-ed home that became a signature during a decade-long run of "Keeping Up With The Kardashians."
The six-bedroom, eight-bath, 8,800-square-foot Hidden Hills, California house is listed for $13.5 million, as <a href="https://www.nytimes.com/2025/02/07/realestate/jenner-kardashian-house-sale.html">The New York Times first reported</a>. It played the backdrop as viewers became acquainted with Jenners' children: Kim, Kylie, Kendall, Kourtney, Khloe, and Rob, during their hit TV show.
"I've shared so many unforgettable memories in this incredible home with my family, and I'm excited to see it start a new chapter with its next owners," Jenner told the Times in a statement.
Don't Miss:
<ul>
<li>CEO of Integris gathered a team of senior investment managers who have $34.22 billion in combined owned and managed assets in the West Coast —<a href="https://www.benzinga.com/money/integris"> here&#8217;s how to invest in their private credit fund that targets 12% annual interest rate.</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>
<h2 class="wp-block-heading">The Backdrop To Branding Juggernaut</h2>
Jenner, 69, has owned the home for 15 years after buying it in 2010 with then-husband and former Olympic athlete Bruce Jenner, who later became Caitlyn Jenner. The couple needed space. Kylie and Kendall Jenner were their biological kids, while each spouse brought four grown kids from previous relationships to the hybrid family.
By the time the Jenners moved in, the show had already been on for three years. The ensuing decade saw the Jenner/Kardashians build an entrepreneurial empire while spending lavishly to upgrade the home. After the Jenners finalized their divorce in 2015, Kris Jenner moved the home into a trust.&nbsp;
The home has been vacant for some time, turning into a TV timepiece —redesigned before its current listing—while Kris Jenner and her family moved between their extensive real estate portfolios.&nbsp;
Trending: Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
<h2 class="wp-block-heading">So Many Homes She Forgot She Owned One</h2>
According to<a href="https://www.realtor.com/news/celebrity-real-estate/kris-jenner-keeping-with-kardashians-house-sale-photos/"> Realtor.com</a>, Jenner and her progeny have been active in the <a href="https://www.benzinga.com/real-estate/24/09/40833294/super-bowl-winning-quarterback-buys-home-from-rapper-drake-lists-property-for-almost-7-million">Hidden Hills </a>real estate market in recent years. Jenner bought a home for $10 million in 2017 — across the street from daughter Kim — selling it three years later after an extensive renovation. In 2020, Kris and Kloe bought adjacent homes, the mother's costing a princely $20 million, before an extensive gut renovation, the results of which were featured on a 2022 episode of "The Kardashians."
In addition to spacious family homes, the brood also owns chic condos dotted around L.A. In fact, they own so many that Kris Jenner openly admitted, during<a href="https://www.dailymail.co.uk/tvshowbiz/article-11243133/Kris-Jenner-look-Kardashian-familys-EXPANSIVE-property-portfolio.html"> Season 2</a> of the show, that she forgot she owned a Beverly Hills condo.
See Also: Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.
<h2 class="wp-block-heading">Billionaires And Simply Multi-Millionaires</h2>
However, Jenner is not the wealthiest of her family members. <a href="https://www.forbes.com/profile/kylie-jenner/">According to Forbes</a>, that honor goes to the ubiquitous <a href="https://www.benzinga.com/general/entertainment/24/11/42055763/kim-kardashian-praises-tesla-design-chief-for-cybercab-design-one-of-the-best-car-designers-ever">Kim Kardashian</a>, who is worth $1.7 billion, while Kylie Jenner is worth a not-too-shabby $710 million. Mom Kris Jenner is in third place with a respectable $170 million.
Unlike the branding bonanza that is her children's careers, Kris Jenner's cash comes from putting deals together and taking a cut for troubles. In Kim&#8217;s case, that means multiple TV shows, two lucrative businesses—KKW Beauty and Skims — and a slew of endorsements and investments.
According to<a href="https://www.forbes.com/profile/kylie-jenner/"> Forbes</a>, Kylie Jenner sold 51% of Kylie Cosmetics to <a href="https://www.benzinga.com/insights/analyst-ratings/25/02/43544383/the-analyst-verdict-coty-in-the-eyes-of-7-experts">Coty Inc</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) in January 2020 for $600 million. She pocketed some $540 million, pretax, with Kris controlling the deal and getting paid. And let's not forget older sisters Kendall Jenner and Khloe Kardashian, each worth around $60 million , while Kourtney Kardashian has about $65 million, according to TheThings. Not bad at all.
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Kris Jenner Puts Her 'Keeping Up With The Kardashian' Mansion On the Market For $13.5 Million. Here's A Look At Her Property Portfolio

Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) reported weaker-than-expected earnings for its second quarter after the <a href="https://www.benzinga.com/quote/COTY/earnings">closing bell on Monday</a>.
Coty posted quarterly earnings of 11 cents per share which missed the analyst consensus estimate of 21 cents per share. The company reported quarterly sales of $1.67 billion which missed the analyst consensus estimate of $1.72 billion.
Sue Nabi, Coty&#8217;s CEO, said, &#8220;As we are now midway through our fiscal year, it is clear that FY25 is shaping up to be a pivotal year. On the one hand, the global beauty market continues to grow at a healthy pace, even if growth has moderated off of the elevated levels of the last few years, which benefited from more material pricing increases. And in this backdrop, fragrances of all price points continue to outperform most other beauty categories, which strongly benefits Coty&#8217;s business as fragrances account for over 60% of our revenues and an even bigger portion of our profits."
Coty&#8217;s shares fell 5.5% to trade at $5.79 on Wednesday.
These analysts made changes to their price targets on Coty following earnings announcement.
<ul>
<li>Morgan Stanley analyst Dara Mohsenian maintained Coty with an Equal-Weight and lowered the price target from $9 to $7.</li>
<li>Canaccord Genuity analyst Susan Anderson maintained Coty with a Buy and lowered the price target from $10 to $8.</li>
<li>Evercore ISI Group analyst Robert Ottenstein maintained the stock with an Outperform and cut the price target from $15 to $10.</li>
<li>Goldman Sachs analyst Patty Kanada maintained Coty with a Neutral and lowered the price target from $9 to $8.</li>
</ul>
Considering buying COTY stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12115556/image-2-34-1024x587.png" alt="" class="wp-image-779217" style="width:577px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12115556/image-2-34-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12115556/image-2-34-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12115556/image-2-34-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12115556/image-2-34.png 1126w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43660222/snowflake-to-rally-around-9-here-are-10-top-analyst-forecasts-for-wednesday">Snowflake To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Earnings

Price Target

Analyst Ratings

These Analysts Cut Their Forecasts On Coty After Downbeat Earnings

WIIM

Coty shares are trading lower after multiple firms cut their respective price targets on the stock.

RBC Capital analyst Nik Modi reiterates Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Outperform and maintains $13 price target.

Reiteration

RBC Capital Reiterates Outperform on Coty, Maintains $13 Price Target

Goldman Sachs analyst Patty Kanada maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Neutral and lowers the price target from $9 to $8.

Goldman Sachs Maintains Neutral on Coty, Lowers Price Target to $8

Evercore ISI Group analyst Robert Ottenstein maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Outperform and lowers the price target from $15 to $10.

Evercore ISI Group Maintains Outperform on Coty, Lowers Price Target to $10

Canaccord Genuity analyst Susan Anderson maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and lowers the price target from $10 to $8.

Canaccord Genuity Maintains Buy on Coty, Lowers Price Target to $8

Morgan Stanley analyst Dara Mohsenian maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Equal-Weight and lowers the price target from $9 to $7.

Morgan Stanley Maintains Equal-Weight on Coty, Lowers Price Target to $7

Stifel analyst Mark S. Astrachan reiterated a Hold rating on the shares of Coty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) and lowered the price forecast from $8.50 to $8.
Coty&#8217;s second-quarter FY25 results showed a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43607951/coty-reports-solid-1h25-financial-performance-with-strong-margin-expansion-and-cash-generation-in-" rel="noreferrer noopener">1% year-over-year decline in net revenue</a> on a like-for-like (LFL) basis, with the Consumer Beauty segment experiencing a 4% LFL drop, while Prestige grew by 1% LFL, noted the analyst.
The decline in Consumer Beauty, which represents around 33% of Coty&#8217;s sales, was driven by ongoing challenges in mass cosmetics and body care, though mass fragrances saw growth.
The Prestige segment, accounting for roughly 67% of Coty&#8217;s sales, was bolstered by growth in prestige fragrances, but was partially offset by declines in prestige cosmetics.
Coty&#8217;s adjusted EBITDA for the quarter reached $391 million, surpassing the consensus estimate of $386 million, marking a 7% year-over-year increase.
The adjusted gross margin stood at 66.8%, reflecting a 170 basis point increase from the previous year, driven by supply chain savings, pricing adjustments, and a reduction in excess and obsolescence charges.
The company lowered its F2025 guidance, projecting a 1% &#8211; 2% decline in organic sales for the second half of the fiscal year (compared to consensus growth of around 3% &#8211; 4%) and adjusted EBITDA between $1.115 billion and $1.125 billion (consensus of $1.177 billion).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43623639/coca-cola-pops-in-q4-revenue-soars-6-ceo-hails-all-weather-strategy" rel="noreferrer noopener">Coca-Cola Pops In Q4—Revenue Soars 6%, CEO Hails &#8216;All-Weather Strategy&#8217;</a>
Coty attributed this outlook to foreign exchange impacts and slowing growth in several categories, especially U.S. mass cosmetics, while prestige fragrances showed more modest deceleration.
The company noted that sell-out continued to outpace its sales, suggesting retailers are still working through inventory reductions, a trend likely to affect future performance, the analyst noted.
Given the ongoing weakness across the beauty sector and global markets, the analyst expected these results and the guidance cut.
The analyst sees a 5% reduction in consensus adjusted EBITDA estimates, with Coty&#8217;s stock expected to drop less than the anticipated revisions due to the already anticipated weakness.
J.P.Morgan analyst Andrea Teixeira reiterated a Neutral rating on the shares. Coty&#8217;s second-quarter adjusted EPS of $0.22, excluding a -$0.11 loss from the mark-to-market of equity swap changes during the quarter, matched the analyst&#8217;s forecast and was a penny above Bloomberg&#8217;s consensus estimate of $0.21.
More notably, the company reduced its guidance once again, projecting weak second-quarter trends to continue into the second half of the year, and warned of a &#8220;broadly similar market environment&#8221; entering FY26, per the analyst.
Key variances from the analyst&#8217;s projections included a higher gross margin (+103 basis points) and lower taxes (-88 basis points below expectations), which were partially offset by disappointing sales results.
The company&#8217;s LFL sales performance also fell short of the expected 1% &#8211; 2% growth for the second-quarter, noted the analyst.
Price Action: COTY shares are trading lower by 7.90% at $6.235 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43592025/fast-food-major-mcdonalds-stocks-rise-despite-q4-sales-miss-details" target="_blank" rel="noreferrer noopener">McDonald&#8217;s Q4 Earnings: Stagnant Revenue Growth, US Comp Sales Decline And More</a></li>
</ul>
Photo by Ground Picture on Shutterstock.

Analyst Color

Equities

Coty Faces Challenges As Category Weakness Lies Ahead, Say Analysts

DA Davidson analyst Linda Bolton Weiser maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and lowers the price target from $12.5 to $12.

DA Davidson Maintains Buy on Coty, Lowers Price Target to $12

Stifel analyst Mark Astrachan maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Hold and lowers the price target from $8.5 to $8.

Stifel Maintains Hold on Coty, Lowers Price Target to $8

Coty shares are trading lower after the company missed Q2 earnings and revenue estimates.

Coty expects LFL sales trends in 2H25 which are broadly consistent with its Q2 LFL sales trend at -1% to -2%. The significant strengthening of the U.S. dollar is expected to drive a more material FX headwind in 2H25 of approximately 3%, resulting in FY25 reported sales declining in the low single digits percentage.
Given the complex retail demand environment, Coty now assumes a broadly similar market environment entering FY26. However, several key brand initiatives and distribution opportunities planned for FY26 should support some gradual improvement in Coty's LFL sales growth.
Finally, Coty expects FY25 free cash flow to grow roughly 10% YoY to approximately $400M. In light of the more uncertain environment for the next couple of quarters, further pressured by FX headwinds, Coty is targeting a year-over-year reduction in leverage exiting CY25 of 0.5x or more, resulting in leverage below 2.5x with the goal to reach closer to 2x, which factors in the cash true-up payment related to Coty's equity swap.&nbsp; &nbsp;

Guidance

Coty Now Expects FY25 Adjusted EPS Excluding Equity Swap Of $0.50 - $0.52 (Est $0.51), Reflecting Mid-to-high Single Digit Percentage Growth (Prior View: Low End Of Prior Guidance Range Of $0.54 - $0.57)

Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.21 by 47.62 percent. This is a 56 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $1.67 billion which missed the analyst consensus estimate of $1.72 billion by 3.02 percent. This is a 3.41 percent decrease over sales of $1.73 billion the same period last year.

Earnings Misses

Coty Q2 2025 Adj EPS $0.11 Misses $0.21 Estimate, Sales $1.67B Miss $1.72B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $431.01 million. 
• Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is expected to report quarterly earnings at $0.79 per share on revenue of $261.34 million. 
• Tower Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSEM#NASDAQ">TSEM</a>) is expected to report quarterly earnings at $0.53 per share on revenue of $387.09 million. 
• Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) is projected to report quarterly earnings at $0.12 per share on revenue of $480.16 million. 
• McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) is estimated to report quarterly earnings at $2.86 per share on revenue of $6.48 billion. 
• Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) is projected to report quarterly earnings at $1.55 per share on revenue of $1.15 billion. 
• CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) is estimated to report earnings for its first quarter. 
• Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) is likely to report quarterly loss at $0.03 per share on revenue of $59.50 million. 
• Motorcar Parts of America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPAA#NASDAQ">MPAA</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $179.50 million. 
• Roivant Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>) is likely to report quarterly loss at $0.22 per share on revenue of $5.00 million. 
• Insperity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSP#NYSE">NSP</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $1.60 billion. 
• GCM Grosvenor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCMG#NASDAQ">GCMG</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $158.60 million. 
• Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) is likely to report quarterly earnings at $1.67 per share on revenue of $1.88 billion. 
• PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $99.43 million. 
• ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $1.76 billion. 
• Alexander's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALX#NYSE">ALX</a>) is estimated to report quarterly earnings at $3.71 per share on revenue of $55.20 million. 
• Loews (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/L#NYSE">L</a>) is expected to report earnings for its fourth quarter. 
• CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) is expected to report quarterly earnings at $1.21 per share on revenue of $3.62 billion. 
• ORIX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IX#NYSE">IX</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) is expected to report quarterly earnings at $1.80 per share on revenue of $3.95 billion. 
• RCI Hospitality Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICK#NASDAQ">RICK</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $81.82 million. 
• Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) is expected to report earnings for its first quarter. 
• Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) is projected to report earnings for its first quarter. 
• Radiant Logistics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RLGT#AMEX">RLGT</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $220.60 million. 
• Cresud SACIF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRESY#NASDAQ">CRESY</a>) is likely to report earnings for its second quarter. 
• Prospect Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSEC#NASDAQ">PSEC</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $189.67 million. 
• SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $447.00 million. 
• SPDR ICE Preferred Securities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSK#NYSE">PSK</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $121.00 million. 
• PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $60.00 million. 
• Quipt Home Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QIPT#NASDAQ">QIPT</a>) is likely to report earnings for its first quarter. 
• RGC Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGCO#NASDAQ">RGCO</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $26.00 million. 
• Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) is projected to report quarterly loss at $0.21 per share on revenue of $375.22 million. 
• Columbus McKinnon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCO#NASDAQ">CMCO</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $252.56 million. 
• Origin Agritech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEED#NASDAQ">SEED</a>) is estimated to report earnings for its Fiscal Year 2024. 
• Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $117.09 million. 
• Unitil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTL#NYSE">UTL</a>) is estimated to report quarterly earnings at $0.95 per share on revenue of $145.00 million. 
• Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $934 thousand. 
• SPS Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPSC#NASDAQ">SPSC</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $169.29 million. 
• Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) is projected to report quarterly earnings at $1.14 per share on revenue of $143.43 million. 
• Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is projected to report quarterly earnings at $1.29 per share on revenue of $498.53 million. 
• Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) is estimated to report quarterly earnings at $4.10 per share on revenue of $2.78 billion. 
• TIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIMB#NYSE">TIMB</a>) is estimated to report earnings for its fourth quarter. 
• Vornado Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNO#NYSE">VNO</a>) is estimated to report quarterly earnings at $0.51 per share on revenue of $447.75 million. 
• Axcelis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLS#NASDAQ">ACLS</a>) is expected to report quarterly earnings at $1.25 per share on revenue of $244.95 million. 
• Arrowhead Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) is likely to report quarterly loss at $1.10 per share on revenue of $14.09 million. 
• Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) is likely to report quarterly earnings at $1.03 per share on revenue of $280.21 million. 
• Apollo Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARI#NYSE">ARI</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $48.20 million. 
• Mitek Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITK#NASDAQ">MITK</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $36.05 million. 
• Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $212.45 million. 
• Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $1.66 billion. 
• Danaos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAC#NYSE">DAC</a>) is estimated to report quarterly earnings at $6.95 per share on revenue of $261.56 million. 
• Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $1.73 billion. 
• Watts Water Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) is estimated to report quarterly earnings at $1.92 per share on revenue of $537.61 million. 
• CoreCivic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $465.17 million. 
• NGL Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGL#NYSE">NGL</a>) is estimated to report quarterly earnings at $0.13 per share on revenue of $1.72 billion. 
• Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) is projected to report quarterly earnings at $3.12 per share on revenue of $535.01 million. 
• Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $127.91 million. 
• Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) is estimated to report quarterly earnings at $0.72 per share on revenue of $232.90 million. 
• Pennant Park Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNNT#NYSE">PNNT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $35.59 million. 
• PennantPark Floating Rate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFLT#NYSE">PFLT</a>) is projected to report quarterly earnings at $0.32 per share on revenue of $59.48 million. 
• Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) is expected to report quarterly earnings at $1.87 per share on revenue of $2.63 billion. 
• Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is projected to report earnings for its fourth quarter. 
• Credicorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAP#NYSE">BAP</a>) is likely to report quarterly earnings at $4.66 per share on revenue of $1.48 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACGL

ACLS

AIOT

ALAB

AMKR

ARKR

ARWR

CINF

CMCO

CRESY

CSPI

FLNC

GCMG

HAIN

HLIT

INCY

INSP

ISPR

LSCC

MEDP

MITK

MNDY

MPAA

PETS

PFLT

PNNT

PSEC

QIPT

RGCO

RICK

RLGT

ROIV

SEED

SLQT

SPSC

TIMB

TSEM

VRTX

XAIR

Earnings Scheduled For February 10, 2025

Across the recent three months, 7 analysts have shared their insights on Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Coty, presenting an average target of $9.71, a high estimate of $12.50, and a low estimate of $6.00. Observing a downward trend, the current average is 12.52% lower than the prior average price target of $11.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1738875663_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Coty among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.50</td>
<td>$12.50</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$7.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.50</td>
<td>$12.50</td>
</tr>
<tr>
<td>Patty Kanada</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$9.00</td>
<td>-</td>
</tr>
<tr>
<td>Oliver Chen</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$8.50</td>
<td>-</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.50</td>
<td>$14.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Coty compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coty's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COTY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coty analyst ratings.</a>
<h2>About Coty</h2>
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.
<h3>Financial Milestones: Coty's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining Coty's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.83% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Coty's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.76%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coty's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.02%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Coty's ROA excels beyond industry benchmarks, reaching 0.65%. This signifies efficient management of assets and strong financial health.
Debt Management: Coty's debt-to-equity ratio is below the industry average at 1.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Coty In The Eyes Of 7 Experts

DA Davidson analyst Linda Bolton Weiser maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and maintains $12.5 price target.

DA Davidson Maintains Buy on Coty, Maintains $12.5 Price Target

Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Coty, presenting an average target of $9.19, a high estimate of $12.50, and a low estimate of $6.00. Highlighting a 13.87% decrease, the current average has fallen from the previous average price target of $10.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1737147678_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Coty is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$7.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.50</td>
<td>$12.50</td>
</tr>
<tr>
<td>Patty Kanada</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$9.00</td>
<td>-</td>
</tr>
<tr>
<td>Oliver Chen</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$8.50</td>
<td>-</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.50</td>
<td>$14.50</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$11.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Coty compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Coty's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coty's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COTY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coty analyst ratings.</a>
<h2>Delving into Coty's Background</h2>
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.
<h3>Coty: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Coty displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 1.83%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Coty's net margin excels beyond industry benchmarks, reaching 4.76%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Coty's ROE stands out, surpassing industry averages. With an impressive ROE of 2.02%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Coty's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.65% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Coty's debt-to-equity ratio is below the industry average at 1.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Coty In The Eyes Of 8 Experts

Press Releases

Coty Launches Scientific Advisory Board on Skincare Innovation

Coty, A Fragrance Disruptor Since 1904

Coty Announces Preliminary First Quarter Results and Reiterates FY25 Adjusted EBITDA Outlook for +9-11% YoY Growth, Supporting Stronger EBITDA Margin Expansion

Coty Achieves Key Milestones and Sets New Targets in FY24 Sustainability Report

Coty Reports Solid Q1 Growth Fueled by Prestige Fragrances, Outperforming Beauty Market

Coty Inc. Announces Cash Tender Offer for Up to $250 Million Outstanding 5.000% Senior Secured Notes due 2026

Coty Inc. Announces Early Results of its Cash Tender Offer for a Portion of its Outstanding 5.000% Senior Secured Notes due 2026

Coty and Swarovski Sign Long-Term Agreement for New Entry Into Beauty Market

Coty Reports Solid 1H25 Financial Performance, With Strong Margin Expansion and Cash Generation in an Uncertain Market Environment

Coty Provides Update on Category Leadership, Financial Progress, and Strategy to Fuel Outperformance of Beauty Market at CAGNY 2025 Conference

PARIS:COTY

AXIL Brands

BellRing Brands

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Usana Health Sciences

Veru

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Coty

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL